| Matthew Coleman, | |
|
5000 W Chambers St, Milwaukee, WI 53210 | |
| (414) 447-2000 | |
| Not Available |
| Full Name | Matthew Coleman |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology Assistant |
| Experience | 12 Years |
| Location | 5000 W Chambers St, Milwaukee, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881946689 | NPI | - | NPPES |
| 1881946689 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | AA2012-004 (New Mexico) | Secondary |
| 367H00000X | Anesthesiologist Assistant | 103 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of New Mexico Hospital | Albuquerque, NM | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of New Mexico Medical Group | 4981795267 | 1002 |
News Archive
The Republican governor said he wants to fix the current system first, but would consider expansion if federal officials allowed the state to craft its own plan.
Applied Genetic Technologies Corporation, a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that it has received a grant of $1 million from the Food and Drug Administration (FDA Orphan Drugs Program). The grant will fund a Phase II Human Clinical Trial evaluating the safety and efficacy of a treatment for Leber congenital amaurosis (LCA), a genetic retinal disease known to cause blindness at an early age.
In a study appearing in the July 5 issue of JAMA, Blayne Welk, M.D., M.Sc., of Western University, London, Canada, and colleagues conducted a study to assess the association between gadolinium exposure and parkinsonism, a degenerative disorder of the central nervous system characterized by tremor and impaired muscular coordination.
Scientists have moved a step closer to an "obesity drug" that may block the effects of diets high in sugar and fats. In a new research report published in the December 2013 issue of The FASEB Journal, scientists show that there is an abnormal amount of an inflammatory protein called PAR2 in the abdominal fat tissue of overweight and obese humans and rats.
Ipsen and Inspiration Biopharmaceuticals Inc. today announced they entered into an Asset Purchase Agreement (APA) whereby Baxter International (Baxter) agrees to acquire the worldwide rights to OBI-1, a recombinant porcine factor VIII (rpFVIII) in development for congenital hemophilia A with inhibitors and acquired hemophilia A, and Ipsen's industrial facility in Milford (Boston, MA).
› Verified 1 days ago
| Entity Name | Unm Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831218627 PECOS PAC ID: 4981795267 Enrollment ID: O20070801000589 |
News Archive
The Republican governor said he wants to fix the current system first, but would consider expansion if federal officials allowed the state to craft its own plan.
Applied Genetic Technologies Corporation, a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that it has received a grant of $1 million from the Food and Drug Administration (FDA Orphan Drugs Program). The grant will fund a Phase II Human Clinical Trial evaluating the safety and efficacy of a treatment for Leber congenital amaurosis (LCA), a genetic retinal disease known to cause blindness at an early age.
In a study appearing in the July 5 issue of JAMA, Blayne Welk, M.D., M.Sc., of Western University, London, Canada, and colleagues conducted a study to assess the association between gadolinium exposure and parkinsonism, a degenerative disorder of the central nervous system characterized by tremor and impaired muscular coordination.
Scientists have moved a step closer to an "obesity drug" that may block the effects of diets high in sugar and fats. In a new research report published in the December 2013 issue of The FASEB Journal, scientists show that there is an abnormal amount of an inflammatory protein called PAR2 in the abdominal fat tissue of overweight and obese humans and rats.
Ipsen and Inspiration Biopharmaceuticals Inc. today announced they entered into an Asset Purchase Agreement (APA) whereby Baxter International (Baxter) agrees to acquire the worldwide rights to OBI-1, a recombinant porcine factor VIII (rpFVIII) in development for congenital hemophilia A with inhibitors and acquired hemophilia A, and Ipsen's industrial facility in Milford (Boston, MA).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Coleman, 5000 W Chambers St, Milwaukee, WI 53210-1650 Ph: (414) 447-2000 | Matthew Coleman, 5000 W Chambers St, Milwaukee, WI 53210 Ph: (414) 447-2000 |
News Archive
The Republican governor said he wants to fix the current system first, but would consider expansion if federal officials allowed the state to craft its own plan.
Applied Genetic Technologies Corporation, a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that it has received a grant of $1 million from the Food and Drug Administration (FDA Orphan Drugs Program). The grant will fund a Phase II Human Clinical Trial evaluating the safety and efficacy of a treatment for Leber congenital amaurosis (LCA), a genetic retinal disease known to cause blindness at an early age.
In a study appearing in the July 5 issue of JAMA, Blayne Welk, M.D., M.Sc., of Western University, London, Canada, and colleagues conducted a study to assess the association between gadolinium exposure and parkinsonism, a degenerative disorder of the central nervous system characterized by tremor and impaired muscular coordination.
Scientists have moved a step closer to an "obesity drug" that may block the effects of diets high in sugar and fats. In a new research report published in the December 2013 issue of The FASEB Journal, scientists show that there is an abnormal amount of an inflammatory protein called PAR2 in the abdominal fat tissue of overweight and obese humans and rats.
Ipsen and Inspiration Biopharmaceuticals Inc. today announced they entered into an Asset Purchase Agreement (APA) whereby Baxter International (Baxter) agrees to acquire the worldwide rights to OBI-1, a recombinant porcine factor VIII (rpFVIII) in development for congenital hemophilia A with inhibitors and acquired hemophilia A, and Ipsen's industrial facility in Milford (Boston, MA).
› Verified 1 days ago
Justin Michael Cole, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 2901 W Kinnickinnic River Pkwy Ste 305, Milwaukee, WI 53215 Phone: 414-649-6000 | |
Mackenzie Lynn Reid, AA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-8700 Fax: 414-259-1522 | |
Aysha T Muhammad, CAA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-8700 Fax: 414-259-1522 | |
Anjali Rajan Menon, AA-C Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-8700 Fax: 414-259-1522 | |
Joseph Shaoul, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 945 N 12th St, Milwaukee, WI 53233 Phone: 414-219-2000 | |
Mrs. Lea Van Heule, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 2900 W Oklahoma Ave, Milwaukee, WI 53215 Phone: 231-288-3155 | |
Sarah Anderson, AA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 2900 W Oklahoma Ave, Milwaukee, WI 53215 Phone: 414-649-6000 |